相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chemopreventive efficacy of silymarin in skin and prostate cancer
Gagan Deep et al.
INTEGRATIVE CANCER THERAPIES (2007)
Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-κB via inhibition of the prosurvival akt signaling pathway
Dorrah Deeb et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Conditional Akt activation promotes androgen-independent progression of prostate cancer
Benyi Li et al.
CARCINOGENESIS (2007)
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Richard S. Jope et al.
NEUROCHEMICAL RESEARCH (2007)
Role that phosphorylation of GSK3 plays in insulin
EJ McManus et al.
EMBO JOURNAL (2005)
Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPAR-γ
CW Shiau et al.
CANCER RESEARCH (2005)
Amiloride potentiates TRAIL-induced tumor cell apoptosis by intracellular acidification-dependent Akt inactivation
YL Cho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Approaches to understanding the importance and clinical implications of peroxisome proliferator-activated receptor gamma (PPARγ) signaling in prostate cancer
M Jiang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-γ ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/x-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by arsenic trioxide
T Kumagai et al.
CLINICAL CANCER RESEARCH (2004)
Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds
R Sinha et al.
CURRENT CANCER DRUG TARGETS (2004)
Role of chemopreventive agents in cancer therapy
T Dorai et al.
CANCER LETTERS (2004)
Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes
AS Wagman et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Glycogen synthase kinase-3β activity is required for androgen-stimulated gene expression in prostate cancer
XB Liao et al.
ENDOCRINOLOGY (2004)
Apoptosis as a novel target for cancer chemoprevention
SY Sun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Prostate carcinoma presentation, diagnosis, and staging - An update from the national cancer data base
DC Miller et al.
CANCER (2003)
GSK-3: tricks of the trade for a multi-tasking kinase
BW Doble et al.
JOURNAL OF CELL SCIENCE (2003)
GSK3 takes centre stage more than 20 years after its discovery
S Frame et al.
BIOCHEMICAL JOURNAL (2001)
Effects of ligand activation of peroxisome proliferator-activated receptor γ in human prostate cancer
E Mueller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
